Bombshell Document Dump on Pfizer Vaccine Data

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @crg_globalresearch.

First published on December 5, 2021, updated December 18, 2021.

Since publication, important new sections of this confidential Pfizer report have been released.

***

“Have you seen the document dump on the Pfizer vaccine data? It’s a bombshell. No wonder the FDA fought to keep it hidden for 55 years.

Here is the quick takeaway:

By February of 2021, Pfizer had already received more than 1,200 reports of deaths allegedly caused by the vaccine and tens of thousands of reported adverse events, including 23 cases of spontaneous abortions out of 270 pregnancies and more than 2,000 reports of cardiac disorders. 

Bear in mind, this is Pfizer’s own data.” Election Wizard

 

***

This Confidential Pfizer Report released as part of a Freedom of Information (FOI) procedure provides data on deaths and adverse events recorded by Pfizer from the outset of the vaccine project in December 2020 to the end of February 2021, namely a very short period (at most two and a half months).

The Pfizer BioNTech vaccine was launched in the US on the 14th of December after the granting of Emergency Use Authorization on December 11, 2020. 

In a twisted irony, the data revealed in this “insider report” refutes the official vaccine narrative peddled by the governments and the WHO. It also confirms the analysis of numerous medical doctors and scientists who have revealed the devastating consequences of the mRNA “vaccine”. 

What is contained in  Pfizer’s “confidential” report is detailed evidence on the impacts of the “vaccine” on mortality and morbidity. This data which emanates from the “Horse’s Mouth” can now be used to confront as well formulate legal procedures against Big Pharma, the governments, the WHO and the media.

In a Court of Law, the evidence contained in this Big Pharma confidential report (coupled with the data on deaths and adverse events compiled by the national authorities in the EU, UK and US) is irrefutable: because it is their data and their estimates and not ours. 

Bear in mind: it’s data which is based on reported and recorded cases, which constitute a small percentage of the actual number of vaccine related deaths and adverse events. 

This is a de facto Mea Culpa on the part of Pfizer. #Yes it is a Killer Vaccine

Pfizer was fully aware that the mRNA vaccine which it is marketing Worldwide would result in a wave of mortality and morbidity. This is tantamount to a crime against humanity on the part of Big Pharma.

Pfizer knew from the outset that it was a killer vaccine. 

It is also a  Mea Culpa and Treason on the part of corrupt national governments Worldwide which are being threatened and bribed by Big Pharma.

Video Interview with Michel Chossudovsky on the The Secret Pfizer Report

Click right corner to access fullscreen

No attempt has been made by the governments to call for the withdrawal of the killer vaccine.

People are told  that the vaccine is intended to save lives.

“Killing is Good for Business”: It is a multibillion dollar operation worldwide. And Pfizer already has a criminal record (2009) with the US  Department of Justice on charges of “fraudulent marketing”.

We invite the “Covid-19 Fact Checkers” to peruse this Confidential Pfizer report.

(Oops. It just so happens that Reuters “Fact Checker” chairman and former Chief Executive Officer (CEO) James C. Smith “is also a top investor and board member of Pfizer”. “No  Conflict of Interest”).

Selected excerpts, tables and diagram from the Report below

 

Michel Chossudovsky.

Global Research, December 5, 2021, Update with Video Interview on May, 17, 2022

 

See author’s Biographical Note

 Archive of Articles on Global Research

Please forward this article

***

 

Click here to read the complete Pfizer report.  

also see details in the Appendices

Selected Excerpts of the Report

This document provides an integrated analysis of the cumulative post-authorization safety data, including U.S. and foreign post-authorization adverse event reports received through 28 February 2021.

(…)

Pfizer is responsible for the management post-authorization safety data on behalf of the MAH BioNTech according to the Pharmacovigilance Agreement in place. Data from BioNTech are included in the report when applicable.

Reports are submitted voluntarily, and the magnitude of underreporting is unknown.

(…)

Cumulatively, through 28 February 2021 [in less than three months], there was a total of 42,086 case reports (25,379 medically confirmed and 16,707 non-medically confirmed) containing 158,893 events. Most cases (34,762) were received from United States (13,739), United Kingdom (13,404) Italy (2,578), Germany (1913), France (1506), Portugal (866) and Spain (756); the remaining 7,324 were distributed among 56 other countries.

(…)

As shown in Figure 1 [see below], the System Organ Classes (SOCs) that contained the greatest number (≥2%) of events, in the overall dataset, were General disorders and administration site conditions (51,335 AEs), Nervous system disorders (25,957), Musculoskeletal and connective tissue disorders (17,283), Gastrointestinal disorders (14,096), Skin and subcutaneous tissue disorders (8,476), Respiratory, thoracic and mediastinal disorders (8,848), Infections and infestations (4,610), Injury, poisoning and procedural complications (5,590), and Investigations (3,693

emphasis added

 

 

 

 

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from BigPharmaNews.com


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


About the author:

Michel Chossudovsky is an award-winning author, Professor of Economics (emeritus) at the University of Ottawa, Founder and Director of the Centre for Research on Globalization (CRG), Montreal, Editor of Global Research. He has undertaken field research in Latin America, Asia, the Middle East, sub-Saharan Africa and the Pacific and has written extensively on the economies of developing countries with a focus on poverty and social inequality. He has also undertaken research in Health Economics (UN Economic Commission for Latin America and the Caribbean (ECLAC), UNFPA, CIDA, WHO, Government of Venezuela, John Hopkins International Journal of Health Services (1979, 1983) He is the author of 13 books including The Globalization of Poverty and The New World Order (2003), America’s “War on Terrorism” (2005), The Globalization of War, America’s Long War against Humanity (2015). He is a contributor to the Encyclopaedia Britannica. His writings have been published in more than twenty languages. In 2014, he was awarded the Gold Medal for Merit of the Republic of Serbia for his writings on NATO’s war of aggression against Yugoslavia. He can be reached at [email protected]

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]